Challenges in the design of trials to evaluate antibacterial agents in serious infections.
Norrby
S R
SR
Department of Infectious Diseases, University of Lund, Sweden.
D002442:Ceftazidime / Q000008:administration & dosage / Q000627:therapeutic use*; D015377:Cilastatin / Q000008:administration & dosage / Q000627:therapeutic use*; D003428:Cross Infection / Q000175:diagnosis / Q000188:drug therapy*; D004338:Drug Combinations; D005060:Europe; D005260:Female; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000188:drug therapy*
D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D002442:Ceftazidime